BioeoconomyProduction process for cell-based coffee p...Scientists led by Heiko Rischer from the Finnish research centre VTT have published the proof of concept for cell-based coffee production. more ➔
NGTGermany blocks deregulation of NGT breedsAt the EU Council (10-11 December), agriculture ministers did not reach the qualified majority required to adopt the adapted version of the EU Commissions draft regulation on new genomic technique … more ➔
financingCathera SA closes Series B round at €42mSorbonne University spin-out Carthera SA has closed its Series B financing round with an additional investment of €4.5m at €42m to launch clinical trials. more ➔
FinancingUK publishes £2bn vision for engineering... On the occasion of SynbiTECH in London, British Science, Research and Innovation Minister, Andrew Griffith, unveiled a £2bn strategic 10-year plan to foster engineering biology. more ➔
Lyme vaccineValnevas Lyme vaccine trial completes recr...Pfizer and Valneva announced the completion of enrolment in Phase 3 VALOR trial for Lyme borreliosis vaccine candidate VLA15. More then 9,000 participants were enrolled. more ➔
cancerUnveiling prostate cancer’s Achilles...Researchers uncover a potential strategy to target and inhibit the androgen receptor in aggressive prostate cancer by exploiting protein droplets. more ➔
Funding$30m for genetic medicine advancementsEligo Bioscience secures $30m in series B funding, advancing its innovative gene-editing solutions targeting diseases linked to bacterial genes within the human microbiome. more ➔
ADCTakeover in ADC space: Abbvie snags Immuno...AbbVie buys ImmunoGen in US$10 billion deal, gains access to ADC for ovarian cancer. The ADC space gets hotter and hotter. more ➔
financingAI protein specialist Cradle raises US$24m...Generative AI protein engineering specialist Cradle NV, has raised US$24m in a Series A financing round led by Index Ventures w more ➔
CGTRepairing MS-caused damage with stem cellsBritish and Italian researchers have demostrated promising results in patients with progressive multiple sclerosis through stem cell transplantation into the brain. more ➔
